Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

336
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
336
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

205
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
205

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[IRM et myocardite infectieuse].

Annales de cardiologie et d'angeiologie·2020
Same author

[TAVI in women, very encouraging results].

Annales de cardiologie et d'angeiologie·2019
Same author

Aortic valve anatomy and outcomes after transcatheter aortic valve implantation in bicuspid aortic valves.

International journal of cardiology·2018
Same author

Novel integrated 3D multidetector computed tomography and fluoroscopy fusion for left atrial appendage occlusion procedures.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2017
Same author

[Transfemoral TAVI procedure in women: Minimally-invasive technique].

Annales de cardiologie et d'angeiologie·2016
Same author

Periodontopathogens antibodies and major adverse events following an acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI).

Journal of epidemiology and community health·2016

Related Experiment Video

Updated: Jan 4, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

467

[TAVR and bicuspid aortic valve].

T Hovasse1, D Tchétché2

  • 1Institut Cardiovasculaire Paris Sud, hôpital privé Jacques-Cartier, Ramsay Santé, Massy, France.

Annales De Cardiologie Et D'Angeiologie
|November 14, 2019
PubMed
Summary
This summary is machine-generated.

Transcatheter aortic valve implantation (TAVI) is now a viable option for patients with bicuspid aortic valves, showing outcomes comparable to tricuspid valves. This approach is suitable for high-risk patients with appropriate anatomy.

Keywords:
Aortic CTBicuspid valveScanner aortiqueSevere aortic stenosisSténose aortique serréeTAVITAVRValve bicuspide

More Related Videos

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.3K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.1K

Related Experiment Videos

Last Updated: Jan 4, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

467
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.3K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.1K

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Percutaneous aortic valve implantation in patients with bicuspid aortic valve (BAV) has historically been controversial and often contraindicated.
  • Advancements in valve technology and anatomical understanding have challenged previous contraindications.

Purpose of the Study:

  • To evaluate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valves (BAV).
  • To compare TAVI outcomes in BAV patients with those in tricuspid aortic valve (TAV) patients.

Main Methods:

  • Review of recent studies and clinical data on TAVI in BAV populations.
  • Analysis of second-generation valve performance and anatomical considerations for TAVI in BAV.

Main Results:

  • Outcomes of TAVI in patients with BAV are now equivalent to those achieved in patients with TAV.
  • Second-generation valves and improved sizing strategies have contributed to these comparable results.

Conclusions:

  • Transcatheter aortic valve implantation (TAVI) can be safely proposed to patients with bicuspid aortic valves (BAV) who are at high or intermediate surgical risk.
  • Patient selection based on suitable anatomy is crucial for successful TAVI in the BAV population.